A polyphasic approach was adopted for analysis of the samples.
The strategy included: i) total DNA extraction from the samples and
subsequent genus, species-specific PCR or both, for the confirmation
of the presence of bacteria (dead or alive) given on the labels of each
commercial probiotic product; ii) differential presumptive enumeration
of the viable probiotic strains in the products; and iii)